Adherence to PRISMA-A and reporting was suboptimal in meta-analysis abstracts on drug efficacy for tumors: a literature survey

To assess the reporting of meta-analysis abstracts on drug efficacy for tumors in terms of adherence to Preferred Reporting Items for Systematic Reviews and Meta-analyses for Abstracts (PRISMA-A) and identify the potential factors associated with adherence to PRISMA-A. A total of 3,211 eligible meta...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of clinical epidemiology Ročník 175; s. 111506
Hlavní autoři: Yan, Baihui, Li, Min, Zhang, Jiaxin, Chang, Hui, Ma, Chi, Li, Fan
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Elsevier Inc 01.11.2024
Elsevier Limited
Témata:
Abstract
Abstracting and Indexing - standards
Abstracting and Indexing - statistics & numerical data
Abstracts
Adherence
Antineoplastic Agents - therapeutic use
Checklist
Clinical medicine
Correlation coefficient
Correlation coefficients
Decision making
Design factors
Drug efficacy
Drug therapy
Effectiveness
Guideline Adherence - statistics & numerical data
Humans
Internal Medicine
Literature reviews
Medical research
Meta-analysis
Meta-Analysis as Topic
Neoplasms - drug therapy
Oncology
PRISMA-A
Statistical analysis
Systematic Reviews as Topic
Tumors
Variance analysis
Adherence
PRISMA-A
Drug efficacy
Abstract
Meta-analysis
Tumors
ISSN:0895-4356, 1878-5921, 1878-5921
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:To assess the reporting of meta-analysis abstracts on drug efficacy for tumors in terms of adherence to Preferred Reporting Items for Systematic Reviews and Meta-analyses for Abstracts (PRISMA-A) and identify the potential factors associated with adherence to PRISMA-A. A total of 3,211 eligible meta-analysis abstracts were assessed using a checklist adapted from the PRISMA-A statement. Adherence to PRISMA-A was analyzed by the total PRISMA-A score and adherence rate (AR). The independent samples t-test was performed to compare the difference of the total scores between two groups with different characteristics, and the analysis of variance or Kruskal-Wallis test was used among multiple groups. The Pearson's correlation coefficient was used to measure the correlation between the word count and the total PRISMA-A score. The mean total score was 8.11 (±1.76) and the AR was 57.94%. The items with lower AR were funding (AR = 0.93%), registration (AR = 3.86%), and risk of bias (AR = 7.85%). Meta-analyses published after the release of PRISMA-A showed better adherence to PRISMA-A. Compared to unstructured abstracts, structured abstracts had a higher AR for each item in PRISMA-A. There was a positive correlation between the word count of abstract and the total PRISMA-A score (r = 0.358, P < .001). Adherence to PRISMA-A was suboptimal in meta-analysis abstracts on drug efficacy for tumors, despite the improvement after the release of PRISMA-A. Various measures should be implemented to improve compliance with PRISMA-A and enhance the reporting of meta-analysis abstracts, including journal endorsement of PRISMA-A, requirement of stricter adherence to PRISMA-A, relaxation of abstract word limits, etc. [Display omitted]
Bibliografie:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0895-4356
1878-5921
1878-5921
DOI:10.1016/j.jclinepi.2024.111506